Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

109 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Patient Preferences with Anti-Vascular Endothelial Growth Factor Treatment for Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema: A Multinational Discrete Choice Experiment Study.
García-Layana A, Chi GC, Kodjikian L, Parravano M, Chow D, Jackson TL, Danzig C, Paris LP, Mirt M, Henry-Szatkowski M, Lewis HB, Gentile B. García-Layana A, et al. Among authors: lewis hb. Ophthalmic Res. 2025;68(1):13-22. doi: 10.1159/000541349. Epub 2024 Nov 21. Ophthalmic Res. 2025. PMID: 39571557 Free article.
Caregiver Experience Survey of Anti-Vascular Endothelial Growth Factor Treatment for Diabetic Macular Edema and Neovascular Age-Related Macular Degeneration.
Viola F, Chi GC, Holekamp NM, Giocanti-Aurégan A, García-Layana A, Peto T, Kertes PJ, Mirt M, Kotecha A, Lambert J, Lewis HB, Gentile B. Viola F, et al. Among authors: lewis hb. Ophthalmic Res. 2024;67(1):516-527. doi: 10.1159/000540390. Epub 2024 Aug 29. Ophthalmic Res. 2024. PMID: 39208778 Free article.
Patient Experience Survey of Anti-Vascular Endothelial Growth Factor Treatment for Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema.
Holekamp N, Gentile B, Giocanti-Aurégan A, García-Layana A, Peto T, Viola F, Kertes PJ, Mirt M, Kotecha A, Lambert J, Lewis HB, Chi GC. Holekamp N, et al. Among authors: lewis hb. Ophthalmic Res. 2024;67(1):311-321. doi: 10.1159/000538975. Epub 2024 Apr 29. Ophthalmic Res. 2024. PMID: 38679018 Free article.
Drivers of and Barriers to Adherence to Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema Treatment Management Plans: A Multi-National Qualitative Study.
Giocanti-Aurégan A, García-Layana A, Peto T, Gentile B, Chi GC, Mirt M, Kosmas CE, Lambert J, Lanar S, Lewis HB, Holekamp NM. Giocanti-Aurégan A, et al. Among authors: lewis hb. Patient Prefer Adherence. 2022 Mar 3;16:587-604. doi: 10.2147/PPA.S347713. eCollection 2022. Patient Prefer Adherence. 2022. PMID: 35264847 Free PMC article.
Effect of Delayed-Release and Extended-Release Methylphenidate on Caregiver Strain and Validation of Psychometric Properties of the Caregiver Strain Questionnaire: Results from a Phase 3 Trial in Children with Attention-Deficit/Hyperactivity Disorder.
López FA, Faraone SV, Newcorn JH, Doll HA, Rhoten S, Lewis HB, Khan TF, DeSousa NJ, Sallee FR, Incledon B. López FA, et al. Among authors: lewis hb. J Child Adolesc Psychopharmacol. 2021 Apr;31(3):179-186. doi: 10.1089/cap.2020.0159. Epub 2021 Apr 1. J Child Adolesc Psychopharmacol. 2021. PMID: 33797983 Free PMC article. Clinical Trial.
109 results